Earnings Feed
Start Free
Arcus Biosciences, Inc.·4

Jun 24, 5:41 PM ET

Jaen Juan C. 4

Research Summary

AI-generated summary

Updated

Arcus Biosciences (RCUS) President Juan Jaen Sells Shares

What Happened

  • Juan C. Jaen, President of Arcus Biosciences (RCUS), sold a total of 31,431 shares in open-market transactions on June 22–24, 2026, realizing about $877,501. The trades were reported as sales (code S) and were effected under a pre-established Rule 10b5-1 trading plan adopted February 27, 2026. These are dispositions (routine sales), not purchases.

Key Details

  • Transactions reported:
    • 2026-06-22: 9,236 shares at a weighted avg $27.03 — proceeds $249,661 (prices ranged $27.00–$27.14) (F2).
    • 2026-06-23: 14,067 shares at a weighted avg $27.69 — proceeds $389,480 (prices ranged $27.01–$28.00) (F3).
    • 2026-06-23: 1,697 shares at a weighted avg $28.06 — proceeds $47,620 (prices ranged $28.0050–$28.1550) (F4).
    • 2026-06-24: 6,431 shares at a weighted avg $29.66 — proceeds $190,740 (prices ranged $29.50–$29.8050) (F5).
  • Total shares sold: 31,431; total reported proceeds: ~$877,501.
  • Shares owned after transaction: not specified in the summary provided here — consult the full Form 4 for the reporting person’s total beneficial ownership (footnotes note inclusion of unvested RSUs and 1,279 ESPP shares) (F6, F7).
  • Notable footnotes: F1 confirms the trades were made under a 10b5-1 plan (adopted Feb 27, 2026). F2–F5 explain each weighted-average price represents multiple executions within stated price ranges. F6/F7 describe components of reported holdings (unvested RSUs; 1,279 ESPP shares).
  • Filing timeliness: Reported period of transactions was June 22, 2026; Form 4 was filed June 24, 2026 (appears timely).

Context

  • Sales executed under a 10b5-1 plan are pre-scheduled transactions that allow insiders to sell shares according to a plan established when they are not in possession of material nonpublic information; such sales are often routine and do not by themselves indicate management sentiment.
  • For retail investors, purchases generally carry more signal value than routine, pre-planned sales. This filing documents sales only — no purchases, exercises, or awards were reported in this Form 4.